Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19

Area of Science:

• Immunology
• Virology
• Pathology

Background:

• The ongoing global COVID-19 pandemic necessitates a deep understanding of SARS-CoV-2's impact on the immune system.
• Investigating immunopathology and pathogen evasion mechanisms is key to explaining differential disease severity in various age groups and those with comorbidities.

Purpose of the Study:

• To explore the immunopathology of SARS-CoV-2, its host immune interactions, and evasion strategies.
• To elucidate why children and young individuals often exhibit milder COVID-19 symptoms compared to the elderly or those with comorbidities.
• To review current vaccine and therapeutic development for COVID-19.

Main Methods:

• Review of scientific literature on SARS-CoV-2 immunopathology.
• Analysis of host-pathogen interactions and immune evasion mechanisms.
• Survey of ongoing vaccine and therapeutic development pipelines.

Main Results:

• Elderly patients and those with comorbidities show distinct immune responses and are more susceptible to severe COVID-19.
• Younger populations often demonstrate more robust immune defenses against SARS-CoV-2.
• Convalescent plasma studies highlight the potential for prolonged immune memory.
• Multiple vaccine and therapeutic candidates are in various stages of clinical trials.

Conclusions:

• Understanding SARS-CoV-2 immunopathology is vital for targeted treatments and vaccine design.
• Immune memory insights from recovered patients can inform future vaccine strategies.
• Accelerated development of vaccines and therapeutics offers hope for managing the current and future outbreaks.